ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER
- 1 October 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 320 (8303) , 842-846
- https://doi.org/10.1016/s0140-6736(82)90810-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologiesCarcinogenesis: Integrative Cancer Research, 1981
- Acetylator phenotyping: A comparison of the isoniazid and dapsone testsEuropean Journal of Clinical Pharmacology, 1981
- Role of N-Acetyltransferase Phenotype in Human Susceptibility To Bladder Carcinogenic ArylaminesScandinavian Journal of Urology and Nephrology, 1980
- Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic methodEuropean Journal of Clinical Pharmacology, 1980
- N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and DenmarkEnvironmental Health Perspectives, 1979
- Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.British Journal of Clinical Pharmacology, 1978
- Hepatic drug acetylation and oxidation: effects of aging in man.BMJ, 1977
- Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other speciesJournal of Toxicology and Environmental Health, 1976
- Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilitiesBiochemical Pharmacology, 1973
- α-Naphthylamine and β-Naphthylamine in Cigarette SmokeNature, 1969